Onderneming Nautilus Biotechnology, Inc.
Aandelen
NAUT
US63909J1088
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,54 USD | -1,17% | +2,01% | -15,05% |
30/04 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
28/02 | Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024 |
Vakgebied
Aantal werknemers: 167
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Parag Mallick
FOU | Founder | 47 | 01-01-16 |
Sujal Patel
FOU | Founder | 49 | 01-01-16 |
Anna Mowry
DFI | Director of Finance/CFO | 46 | 09-06-21 |
Mary Godwin
COO | Chief Operating Officer | 65 | 01-01-20 |
Public Communications Contact | - | 01-01-21 | |
Nick Nelson
PRN | Corporate Officer/Principal | 41 | 09-06-21 |
Martin Huber
PRN | Corporate Officer/Principal | - | 01/11 |
Subra Sankar
PRN | Corporate Officer/Principal | 64 | 01-12-20 |
Matthew Murphy
LAW | General Counsel | 59 | 09-06-21 |
Gwen Weld
HRO | Human Resources Officer | 66 | 12-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Posard
CHM | Chairman | 56 | 01-01-19 |
Farzad Nazem
BRD | Director/Board Member | 62 | 09-06-21 |
Matt McIlwain
BRD | Director/Board Member | 59 | 09-06-21 |
Sujal Patel
FOU | Founder | 49 | 01-01-16 |
Michael Altman
BRD | Director/Board Member | 42 | 09-06-21 |
Melissa Epperly
BRD | Director/Board Member | 46 | 09-06-21 |
Vijay Pande
BRD | Director/Board Member | 53 | 09-06-21 |
Parag Mallick
FOU | Founder | 47 | 01-01-16 |
Karen Akinsanya
BRD | Director/Board Member | 56 | 30-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 125 265 015 | 70 209 342 ( 56,05 %) | 0 | 56,05 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,05% | 322 mln. | |
+0,17% | 42,86 mld. | |
+10,92% | 42,74 mld. | |
+44,30% | 41,36 mld. | |
-6,20% | 27,68 mld. | |
+5,23% | 25,15 mld. | |
-24,79% | 18,63 mld. | |
+26,69% | 12,37 mld. | |
-3,13% | 11,92 mld. | |
+6,57% | 11,21 mld. |
- Beurs
- Aandelen
- Koers NAUT
- Onderneming Nautilus Biotechnology, Inc.